July 16, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
An investigational vaccine that targets common KRAS mutations induced durable immune responses among individuals at high risk for pancreatic cancer, results of a phase 1 clinical trial showed.Eighteen of 20 participants achieved KRAS-specific T-cell responses. Several individuals had either complete radiographic resolution or regression of pancreatic cysts, and none developed pancreatic cancer by
July 16, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Vacuna experimental para prevenir el cáncer de páncreas ofrece una respuesta inmunitaria significativa

Una vacuna experimental contra el cáncer de páncreas mostró resultados positivos en personas de alto riesgo

Cancro al pancreas, primi test di un vaccino contro la mutazione Kras

Prevenire il tumore del pancreas con un vaccino: positivi i primi test sull’uomo

Tumore al pancreas, ecco il vaccino per prevenirlo: positivi i primi test sull’uomo | Libero Quotidiano.it

Prevenire il cancro al pancreas con un vaccino, la 'speranza' dei ricercatori e i primi test

A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come

Cancro al pancreas, la speranza di un vaccino per prevenirlo: lo studio e i primi test

Durable immune response seen in patients with cancer precursor lesions

El producto generó respuestas inmunitarias duraderas destinadas a prevenir este tumor en personas con alto riesgo.

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug,…

La desarrollaron investigadores de la Universidad Johns Hopkins. La formulación demostró un perfil de seguridad favorable y…

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in…

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small UCLA…